Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 345-351

  Joly Guillou, Marie Laure ^a   Wolff, Michel ^a   Pocidalo, Jean Jacques ^a   Walker, Francine ^a   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM;

ACINETOBACTER; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0031039715     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.345     Document Type: Article

References (31)

1. Allen, K. D., and H. T. Green. 1987. Hospital outbreak of multi-resistant Acinetobacter anitratus: an airborne mode of spread. J. Hosp. Infect. 9:110-119.
2. Anstey, N. W., B. J. Currie, and K. M. Withnall. 1992. Community-acquired Acinetobacter pneumonia in the northern territory of Australia. Clin. Infect. Dis. 14:83-91.
3. Benoni, G., L. Cuzzolin, C. Bertrand, G. Pucchetti, and G. Velo. 1987. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients. Chemotherapy 6:259-260.
4. Bick, J. A., and J. D. Semel. 1993. Fulminant community-acquired Acinetobacter pneumonia in a healthy woman. Clin. Infect. Dis. 17:820-821.
5. Brogard, J. M., M. Pinguet, M. Dorner, and J. Lavillaureix. 1976. Etablissement d'un profil pharmacocinétique d'un antibiotique: intérêt pratique et application à l'étude comparative des céphalosporines. Bull. Inst. Pasteur 74:383-412.
6. Brown, D., and P. Rothery. 1993. Structured stochastic models: models with both deterministic and stochastic elements, p. 123-158. In D. Brown and P. Rothery (ed.), Models in biology: mathematics, statistics and computing. John Wiley & Sons, Ltd., Chichester, England.
7. Bustamante, C. I., G. L. Drusano, B. A. Tatem, and H. C. Standiford. 1984. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:678-682.
8. Buxton, A. E., R. L. Anderson, D. Werdegard, and E. Atlas. 1978. Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus: epidemiologic characteristics. Am. J. Med. 65:507-513.
9. Craig, W. A., and S. Gudmundsson. 1986. The postantibiotic effect, p. 515-536. In V. Lorian (ed.), Antibiotics in laboratory medicine, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
10. Daikos, G. L., V. T. Lolans, and G. G. Jackson. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35:117-123.
11. Esposito, A. L., and J. F. Pennington. 1984. Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment. J Infect. Dis. 149:728-734.
12. Fagon, J. Y., J. Chastre, Y. Domart, J. L. Trouillet, J. Pierre, C. Darne, and C. Gibert. 1989. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am. Rev. Respir. Dis. 139:877-884.
13. Fantin, B., J. Legett, S. Ebert, and W. A. Craig. 1991. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model. Antimicrob. Agents Chemother. 35: 1413-1422.
14. Gerber, A. U., H. P. Brugger, C. Feller, T. Stritzko, and B. Stalder. 1986. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153:90-97.
15. Gottfredsson, M., H. Erlendsdottir, A. Gudmundsson, and S. Gudmundsson. 1995. Different patterns of bacterial DNA synthesis during postantibiotic effect. Antimicrob. Agents Chemother. 39:1314-1319.
16. Gudmundsson, S., B. Vogelman, and W. A. Craig. 1986. The in vivo post-antibiotic effect of imipenem and other new antimicrobials. J. Antimicrob. Chemother. 18:67-73.
17. Hashizume, T., Y. Okumoto, M. Ogashiwa, and K. Shimano. 1987. Penetration of imipenem and other antibiotics into inflammatory exudate and their efficacy in pseudomonas infection in the rat granuloma pouch model. J. Antimicrob. Chemother. 20:413-416.
18. Hessen, M. T., P. G. Pitsakis, and M. E. Levison. 1988. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. J. Infect. Dis. 158:542-548.
19. Joly-Guillou, M. L., E. Bergogne-Berezin, and J. F. Vieu. 1991. Epidemiology of Acinetobacter strains isolated from nosocomial infections in France, p. 63-68. In K. J. Towner, E. Bergogne-Berezin, and C. A. Fewson (ed.), The biology of acinetobacter. Plenum Press, New York, N.Y.
20. MacKenzie, F. M., and I. M. Gould. 1993. The post-antibiotic effect. J. Antimicrob. Chemother. 32:519-537.
21. Majcherczyk, P. A., and D. M. Livermore. 1990. Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenems. J. Antimicrob. Chemother. 26:593-594.
22. Obana, Y., T. Nishino, and T. Tanino. 1985. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 15:441-448.
23. Obana, Y. 1986. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol. Immunol. 30:645-657.
24. Odenholt, I., E. Löwdin, and O. Cars. 1994. The effect of repeated dosage of antibiotics during the postantibiotic phase, abstr. A116, p. 120. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
25. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
26. Torres, A., R. Aznar, J. M. Gatell, P. Jimenez, J. Gonzales, A. Ferrer, R. Celis, and R. Rodriguez-Roisin. 1990. Incidence risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:522-528.
27. Vallée, E., E. Azoulay-Dupuis, J. J. Pocidalo, and E. Bergogne-Bérézin. 1992. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Antimicrob. Agents Chemother. 36:1412-1417.
28. Veber, B., E. Vallée, J. M. Desmont, J. J. Pocidalo, and E. Azoulay-Dupuis. 1993. Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia. J. Antimicrob. Chemother. 32:473-482.
29. Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Bergara, R. Reig, R. Gomez-Lus, and T. Jimenez de Anta. 1993. In-vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
30. Wolff, M., and M. L. Joly-Guillou. 1995. In-vitro and in-vivo studies of postantibiotic effect of imipenem against Acinetobacter baumannii, abstr. A98, p. 19. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
31. Yan, S., G. A. Bohach, and D. L. Stevens. 1994. Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes. J. Infect. Dis. 170:609-614.